Home > Insider Trading > Filing (0001179110-18-011179)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1034842	Rigel Pharmaceuticals Inc	RIGL	Pharmaceutical Preparations (2834)	943248524

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1419579	Anne-Marie Duliege	Rigel Pharmaceuticals, Inc. 1180 Veterans Boulevard South San Francisco CA 94080	Evp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-04	16,500	$2.54	16,500	No	4	M	Direct
Common Stock	Disposition	2018-09-04	16,500	$3.51	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employe Stock Option (right to buy)	Disposition	2018-09-04	16,500	$0.00	16,500	$2.54

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
383,500		2026-05-05	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $3.50 to $3.53. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the shares sold at each such separate price.
One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.